Law and Policy of Psychedelic Medicine: Panel five, Part I: Legalization and access
June 25, 2024
Petrie-Flom Center 2024 Annual Conference: Law and Policy of Psychedelic Medicine
Panel five, Part I: Legalization and access
This conference, which will seed a book, seeks to explore the law and policy challenges and opportunities resulting from increased clinical research, private investment, and political interest in psychedelic medicines.
Panelists:
Moderator: Susannah Baruch, Executive Director, The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School
Can psychedelics trigger psychotic disorders in young people? Towards evidence-based public policy for risk management in psychedelic legalization
Hyun Jung Kim, Founder and Director of Psychiatric Training and Outreach, Clinical High Risk for Psychosis (CHR-p) Program; Child and Adolescent Psychiatrist, Division of Psychotic Disorders, McLean Hospital; and Instructor in Psychiatry, Harvard Medical School
Beyond the trip: A legal odyssey charting the course for psychedelic innovation through law and policy
Shahin Shams, Data Curator, Porta Sophia
The ghosts of psychedelic science: Haunting and moral repair
Phoebe Friesen, Assistant Professor, Biomedical Ethics Unit and the Department of Social Studies of Medicine, McGill University
Learn more at https://petrieflom.law.harvard.edu/events/details/law-and-policy-of-psychedelic-medicine
June 25, 2024
Petrie-Flom Center 2024 Annual Conference: Law and Policy of Psychedelic Medicine
Panel five, Part I: Legalization and access
This conference, which will seed a book, seeks to explore the law and policy challenges and opportunities resulting from increased clinical research, private investment, and political interest in psychedelic medicines.
Panelists:
Moderator: Susannah Baruch, Executive Director, The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School
Can psychedelics trigger psychotic disorders in young people? Towards evidence-based public policy for risk management in psychedelic legalization
Hyun Jung Kim, Founder and Director of Psychiatric Training and Outreach, Clinical High Risk for Psychosis (CHR-p) Program; Child and Adolescent Psychiatrist, Division of Psychotic Disorders, McLean Hospital; and Instructor in Psychiatry, Harvard Medical School
Beyond the trip: A legal odyssey charting the course for psychedelic innovation through law and policy
Shahin Shams, Data Curator, Porta Sophia
The ghosts of psychedelic science: Haunting and moral repair
Phoebe Friesen, Assistant Professor, Biomedical Ethics Unit and the Department of Social Studies of Medicine, McGill University
Learn more at https://petrieflom.law.harvard.edu/events/details/law-and-policy-of-psychedelic-medicine
){kind=link}
Comments